| Dr Jason John Dewitt, MD | |
|
1025 Marsh St, Mankato, MN 56001 | |
| (507) 345-2649 | |
| Not Available |
| Full Name | Dr Jason John Dewitt |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 19 Years |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629119771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2005018831 (Missouri) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 51692 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System - Mankato | Mankato, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
News Archive
Keep that pen and paper by the bed: new research by an Australian National University (ANU) PhD graduate suggests it may be that our most creative thoughts come when we're lying down.
Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Keep that pen and paper by the bed: new research by an Australian National University (ANU) PhD graduate suggests it may be that our most creative thoughts come when we're lying down.
Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-fairmont |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366410862 PECOS PAC ID: 4981694981 Enrollment ID: O20040719000142 |
News Archive
Keep that pen and paper by the bed: new research by an Australian National University (ANU) PhD graduate suggests it may be that our most creative thoughts come when we're lying down.
Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740256668 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003933 |
News Archive
Keep that pen and paper by the bed: new research by an Australian National University (ANU) PhD graduate suggests it may be that our most creative thoughts come when we're lying down.
Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1124035282 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003939 |
News Archive
Keep that pen and paper by the bed: new research by an Australian National University (ANU) PhD graduate suggests it may be that our most creative thoughts come when we're lying down.
Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason John Dewitt, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (651) 267-5000 | Dr Jason John Dewitt, MD 1025 Marsh St, Mankato, MN 56001 Ph: (507) 345-2649 |
News Archive
Keep that pen and paper by the bed: new research by an Australian National University (ANU) PhD graduate suggests it may be that our most creative thoughts come when we're lying down.
Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Stratatech Corp., a privately-held regenerative medicine company, today announced that it will launch its StrataTest full-thickness human skin model to the European market at EUROTOX 2009, the annual meeting of the Federation of European Toxicologists and the European Societies of Toxicology. This year's meeting is being held in Dresden, Germany, Sept. 13-16.
› Verified 5 days ago
Stephen D Penkhus, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1230 E Main St, Mankato, MN 56002 Phone: 507-625-1811 | |
Tara Jean Denke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main Street, Mankato Clinic At Main Street, Mankato, MN 56002 Phone: 507-625-1811 | |
Dr. Salvador Javier Cardenas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-790-7070 | |
Dr. Tarek Khalife, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Dr. Scott J Barnacle, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1230 E Main Street, Mankato, MN 56002 Phone: 507-625-1811 | |
Dr. Heather R Carlson, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1230 E. Main Street, Mankato Clinic At Main Street, Mankato, MN 56002 Phone: 507-625-1811 | |
Dr. Amy L. Brien, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1015 Marsh St, Mankato, MN 56001 Phone: 507-385-4842 |